08/07/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2025
6:34 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/04/2025
6:33 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2025
6:24 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/22/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2025
1:44 PM | Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
| Form SCHEDULE 13G/A | |
07/10/2025
6:39 PM | Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
| Form SCHEDULE 13G/A | |
07/10/2025
6:44 PM | Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
| Form SCHEDULE 13G/A | |
07/10/2025
6:50 PM | Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
| Form SCHEDULE 13G/A | |
07/08/2025
7:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/30/2025
9:26 AM | Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for QNTM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Quantum Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
06/27/2025
3:30 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/23/2025
2:34 PM | Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
| Form SCHEDULE 13D/A | |
06/23/2025
10:29 AM | Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
| Form SCHEDULE 13D/A | |
06/17/2025
7:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/16/2025
8:53 PM | Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
| Form SCHEDULE 13D/A | |
06/13/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2025
5:15 PM | Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
| Form SCHEDULE 13D | |
06/11/2025
2:26 PM | Malone Wealth Ventures LLC (Filed by)
Quantum Biopharma Ltd. (Subject)
Quantum Biopharma (Subject)
| Form SCHEDULE 13G | |
06/10/2025
7:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2025
6:50 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025
7:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2025
7:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/19/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2025
7:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025
9:01 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2025
8:34 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/14/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/01/2025
5:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2025
12:53 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/28/2025
5:09 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Sell this, buy that (Ad) What you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strategy: Sell This, Buy That.
In his newest presentation, Eric reveals 7 new trade ideas—pairing overhyped, vulnerable stocks with lesser-known opportunities showing real upside. These contrarian picks come from the same approach that helped him beat Wall Street legends 10-to-1 in Portfolios with Purpose. Click here to see all 7 trade ideas, including full tickers and analysis—100% free. |
03/27/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2025
6:00 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/10/2025
9:18 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/04/2025
6:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/21/2025
3:00 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/17/2025
6:31 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025
7:30 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/07/2025
7:32 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2024
8:16 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/25/2024
6:22 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024
6:31 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/22/2024
6:54 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
7:50 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/07/2024
6:32 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024
7:09 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
6:27 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024
6:39 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2024
8:22 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024
8:46 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024
7:20 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 424B5 | |
08/26/2024
5:18 AM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024
4:18 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K/A | |
08/15/2024
7:15 PM | Quantum Biopharma Ltd. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
6:07 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
5:13 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
5:15 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K/A | |
08/12/2024
5:03 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/09/2024
6:30 AM | FSD Pharma Inc. (Filer)
Quantum Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
